SOFIA (Bulgaria), May 18 (SeeNews) - Bulgarian veterinary drug maker Biovet [BUL:53B] said its consolidated net profit soared to 2.3 million levs ($1.3 million/1.2 million euro) in the first quarter from 249,000 levs in the same period last year.